These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24795224)

  • 21. New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems' impacts.
    Torres-Rueda S; Burchett HE; Griffiths UK; Ongolo-Zogo P; Edengue JM; Kitaw Y; Molla M; Gelmon L; Onyango-Ouma W; Konate M; Mounier-Jack S
    Afr Health Sci; 2015 Sep; 15(3):868-77. PubMed ID: 26957976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination strategies for measles control and elimination: time to strengthen local initiatives.
    Cutts FT; Ferrari MJ; Krause LK; Tatem AJ; Mosser JF
    BMC Med; 2021 Jan; 19(1):2. PubMed ID: 33397366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving immunization capacity in Ethiopia through continuous quality improvement interventions: a prospective quasi-experimental study.
    Manyazewal T; Mekonnen A; Demelew T; Mengestu S; Abdu Y; Mammo D; Abebe W; Haffa B; Zenebe D; Worku B; Aman A; Tigabu S
    Infect Dis Poverty; 2018 Nov; 7(1):119. PubMed ID: 30497515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful polio supplementary immunisation activities in a security compromised zone - Experiences from the Southwest region of Cameroon.
    Haddison EC; Ngono D; Kouamen GT; Kagina BM
    Vaccine; 2018 Nov; 36(46):6961-6967. PubMed ID: 30314909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.
    Habib MA; Soofi S; Cousens S; Anwar S; Haque NU; Ahmed I; Ali N; Tahir R; Bhutta ZA
    Lancet Glob Health; 2017 Jun; 5(6):e593-e603. PubMed ID: 28495264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria.
    Peter KB; Ademola AS; Oyeku OA
    Afr Health Sci; 2014 Mar; 14(1):131-5. PubMed ID: 26060469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The introduction of 'No jab, No school' policy and the refinement of measles immunisation strategies in high-income countries.
    Trentini F; Poletti P; Melegaro A; Merler S
    BMC Med; 2019 May; 17(1):86. PubMed ID: 31096986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of conflict on infant immunisation coverage in Afghanistan: a countrywide study 2000-2003.
    Mashal T; Nakamura K; Kizuki M; Seino K; Takano T
    Int J Health Geogr; 2007 Jun; 6():23. PubMed ID: 17555557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
    Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seasonal gaps in measles vaccination coverage in Madagascar.
    Mensah K; Heraud JM; Takahashi S; Winter AK; Metcalf CJE; Wesolowski A
    Vaccine; 2019 Apr; 37(18):2511-2519. PubMed ID: 30940486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles resurgence in southern Africa: challenges to measles elimination.
    Shibeshi ME; Masresha BG; Smit SB; Biellik RJ; Nicholson JL; Muitherero C; Shivute N; Walker O; Reggis K; Goodson JL
    Vaccine; 2014 Apr; 32(16):1798-807. PubMed ID: 24530936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines - Experiences from Tanzania.
    Mohamed N; Simba D; Mphuru A; Lyimo D; Kyesi F
    Vaccine; 2020 Nov; 38(49):7741-7746. PubMed ID: 33164797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.
    Fields R; Dabbagh A; Jain M; Sagar KS
    Vaccine; 2013 Apr; 31 Suppl 2():B115-21. PubMed ID: 23598472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing nationwide measles supplemental immunization activities in Ethiopia in the context of COVID-19: process and lessons learnt.
    Nigus M; Zelalem M; Abraham K; Shiferaw A; Admassu M; Masresha B
    Pan Afr Med J; 2020; 37(Suppl 1):36. PubMed ID: 33456660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a malaria vaccine for Papua New Guinea.
    Reeder JC
    P N G Med J; 2001; 44(1-2):17-23. PubMed ID: 12418674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis.
    Trentini F; Poletti P; Merler S; Melegaro A
    Lancet Infect Dis; 2017 Oct; 17(10):1089-1097. PubMed ID: 28807627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pakistan's expanded programme on immunization: an overview in the context of polio eradication and strategies for improving coverage.
    Owais A; Khowaja AR; Ali SA; Zaidi AK
    Vaccine; 2013 Jul; 31(33):3313-9. PubMed ID: 23707167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.